About

Interferon beta is a crucial cytokine, a member of the broader interferon family, naturally synthesized by the body to orchestrate and regulate various immune responses. Recombinant human interferon beta is a cornerstone therapy primarily indicated for the management of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. While its precise mechanism of action in MS remains an area of ongoing research, it is widely believed to exert its therapeutic effects through multifaceted immunomodulatory actions. These include reducing inflammation within the central nervous system, diminishing the migration of inflammatory immune cells across the blood-brain barrier, and potentially influencing neurotrophic factors. Ultimately, this therapeutic intervention aims to significantly reduce the frequency and severity of MS relapses, slow the accumulation of disability, and improve the overall long-term prognosis for individuals living with MS.

Uses

Relapsing-remitting multiple sclerosis (RRMS).
Secondary progressive multiple sclerosis (SPMS) with relapses.
Clinically isolated syndrome (CIS) suggestive of MS.
Reduction of relapse rate and disability progression in MS.

Directions For Use

Administered via subcutaneous or intramuscular injection, typically several times a week or every other day. Self-administration is common after proper training.

Benefits

Reduces the frequency of MS relapses.
Slows the progression of disability in MS.
Decreases the number of new brain lesions.
Modulates the immune system in MS.
Improves quality of life for MS patients.
Established long-term efficacy in MS management.

Side Effects

Flu-like symptoms (fever, chills, muscle aches)
Headache
Fatigue
Injection site reactions (pain, redness, swelling)
Elevated liver enzymes
Depression
Leukopenia (decreased white blood cells)
Thrombocytopenia (decreased platelets)
Thyroid dysfunction
Seizures (rare)
Congestive heart failure (rare)
Autoimmune hepatitis (rare)

Safety Measures

Alcohol - Avoid or limit alcohol consumption, as it may increase the risk of liver damage, a potential side effect of this medication.
Pregnancy - Not recommended during pregnancy. Women of childbearing potential should use effective contraception. Consult a doctor.
Breastfeeding - It is unknown if this medication passes into breast milk. A decision should be made whether to discontinue breastfeeding or the drug.
Liver - Use with caution in patients with pre-existing liver disease. Regular monitoring of liver function tests is essential.
Kidney - Use with caution in patients with severe renal impairment; dosage adjustment may be necessary.
Lung - No specific direct lung effects, but patients with pre-existing pulmonary conditions should be monitored for any new or worsening symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location